Coronavirus disease 2019 (COVID-19) is a systemic disease that impacts multiple organ
systems with a complex clinical presentation and outcomes that can vary from person to …

The long view on living with COVID-19 as an endemic disease calls for expanding the
planetary health intervention toolbox. We will need a battery of vaccines, small molecule oral …

We live in truly exciting and challenging times for drug and vaccine development. A case in
point is the COVID-19 pandemic. There remain wide global disparities in access to vaccines …

Purpose: This study introduces a sophisticated computational pipeline, eVir, designed for
the discovery of antiviral drugs based on their interactions within the human protein network …

The deadly global outbreak of COVID-19 has forged an unrivaled threat to human
civilization. Contemplating its profuse impact, initial risk management and therapies are …

Currently, human infections with the severe acute respiratory syndrome coronavirus type 2
(SARS-CoV-2) are accelerating the ongoing spread of the pandemic. Several innovative …

Coronaviruses are a group of enveloped viruses with non-segmented, single-stranded, and
positive-sense RNA genomes. In December 2019, an outbreak of coronavirus disease 2019 …

Background: The newly emerged coronavirus SARS-CoV-2, first reported in December
2019, has infected about five and a half million people globally and resulted in nearly …

In December 2019, a new type of viral pneumonia emerged in Wuhan, Hubei Province,
China. Subsequently, the World Health Organization (WHO) named this unknown virus as …

Coronavirus disease 2019 (COVID-19) displays a broad spectrum of clinical presentations
ranging from lack of symptoms to severe multiorgan system complications and death …